Carpmaels & Ransford has been recognised as a leading patent firm in the Financial Times Europe’s Leading Patent Law Firms 2024 rankings for another year.

The firm is rated as gold for Biotechnology, Food & Healthcare, and Chemistry & Pharmacy. This annual listing ranks Europe’s most highly regarded firms for patent prosecution and patent strategy consultation. Research for this is based on over 3,300 clients and peers’ recommendations.

This top-tier rating continues to demonstrate Carpmaels & Ransford’s strong position as market leaders in the Healthcare and Life Sciences sectors. It follows our recent award win for Patent Litigation Firm of the Year for Biotech at the LMG Life Sciences EMEA Awards 2024.